Latest filing published 01 Mar 2013 for INTERMUNE INC, €48k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Jonathan S. Leff is a declared insider at 7 companies; the most frequent names are Zymogenetics Inc, Intermune Inc and Allos Therapeutics Inc. The record holds 248 filings, for trades running from 31 January 2006 to 28 February 2013.
The open-market record is one-sided, with 234 purchases worth €75.1M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants and 1 option exercise.
A typical purchase (the median) is worth €15k.
The record was last updated on 1 March 2013 with a share grant (€48k) in Intermune Inc. The last purchase on record was published on 27 January 2010, which is 6,114 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations